What do patients consider when making decisions about treatment for hepatitis C?

Fraenkel, Liana; McGraw, Sarah; Wongcharatrawee, Suchat; Garcia-Tsao, Guadalupe

doi:10.1016/j.amjmed.2005.05.029

« Previous Next »The American Journal of Medicine
Volume 118, Issue 12 , Pages 1387-1391, December 2005

What do patients consider when making decisions about treatment for hepatitis C?

Liana Fraenkel, MD, MPH
- Department of Medicine, VA Connecticut Healthcare System, West Haven, Conn
- Department of Medicine, Yale University School of Medicine, New Haven, Conn
- Requests for reprints should be addressed to Liana Fraenkel, MD, MPH, Yale University School of Medicine, Section of Rheumatology, 300 Cedar St, TAC#525, PO Box 208031, New Haven, CT 06520-8031
Sarah McGraw, PhD
- New England Research Institutes, Watertown, Mass
Suchat Wongcharatrawee, MD
- Department of Medicine, VA Connecticut Healthcare System, West Haven, Conn
- Department of Medicine, Yale University School of Medicine, New Haven, Conn
- Hepatitis C Resource Center, VA Connecticut Healthcare System, New Haven, Conn.
Guadalupe Garcia-Tsao, MD
- Department of Medicine, VA Connecticut Healthcare System, West Haven, Conn
- Department of Medicine, Yale University School of Medicine, New Haven, Conn
- Hepatitis C Resource Center, VA Connecticut Healthcare System, New Haven, Conn.

To access this article, please choose from the options below

This study was funded by the VA Health Services Research Department and the Yale Liver Center Pilot Project Grant DK P3034989. Dr. Fraenkel is also supported by the K23 Award AR048826-01 A1.